EP1139751A4 - TRANSFERT EFFICACE ET STABLE $i(IN VIVO) DE GENES DANS DES CARDIOMYOCYTES A L'AIDE DE VECTEURS VIRAUX ADENO-ASSOCIES DE RECOMBINAISON - Google Patents

TRANSFERT EFFICACE ET STABLE $i(IN VIVO) DE GENES DANS DES CARDIOMYOCYTES A L'AIDE DE VECTEURS VIRAUX ADENO-ASSOCIES DE RECOMBINAISON

Info

Publication number
EP1139751A4
EP1139751A4 EP99967703A EP99967703A EP1139751A4 EP 1139751 A4 EP1139751 A4 EP 1139751A4 EP 99967703 A EP99967703 A EP 99967703A EP 99967703 A EP99967703 A EP 99967703A EP 1139751 A4 EP1139751 A4 EP 1139751A4
Authority
EP
European Patent Office
Prior art keywords
cardiomyocytes
vivo
efficient
stable
gene transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP99967703A
Other languages
German (de)
English (en)
Other versions
EP1139751A1 (fr
Inventor
Jeffrey M Leiden
Eric Svensson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arch Development Corp
Original Assignee
Arch Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Development Corp filed Critical Arch Development Corp
Publication of EP1139751A1 publication Critical patent/EP1139751A1/fr
Publication of EP1139751A4 publication Critical patent/EP1139751A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99967703A 1998-12-28 1999-12-28 TRANSFERT EFFICACE ET STABLE $i(IN VIVO) DE GENES DANS DES CARDIOMYOCYTES A L'AIDE DE VECTEURS VIRAUX ADENO-ASSOCIES DE RECOMBINAISON Ceased EP1139751A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11392398P 1998-12-28 1998-12-28
US113923P 1998-12-28
PCT/US1999/031093 WO2000038518A1 (fr) 1998-12-28 1999-12-28 Transfert efficace et stable in vivo de genes dans des cardiomyocytes a l'aide de vecteurs viraux adeno-associes de recombinaison

Publications (2)

Publication Number Publication Date
EP1139751A1 EP1139751A1 (fr) 2001-10-10
EP1139751A4 true EP1139751A4 (fr) 2003-03-19

Family

ID=22352321

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99967703A Ceased EP1139751A4 (fr) 1998-12-28 1999-12-28 TRANSFERT EFFICACE ET STABLE $i(IN VIVO) DE GENES DANS DES CARDIOMYOCYTES A L'AIDE DE VECTEURS VIRAUX ADENO-ASSOCIES DE RECOMBINAISON

Country Status (5)

Country Link
EP (1) EP1139751A4 (fr)
JP (1) JP2002533359A (fr)
AU (1) AU763049B2 (fr)
CA (1) CA2356551A1 (fr)
WO (1) WO2000038518A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034208A1 (fr) * 1999-11-05 2001-05-17 The Regents Of The University Of California Techniques et compositions permettant de traiter les maladies cardiovasculaires par l'administration de genes in vivo
US7745416B2 (en) * 1995-04-11 2010-06-29 The Regents Of The University Of California Method for in vivo regulation of cardiac muscle contractility
EP1870473A1 (fr) * 2000-08-17 2007-12-26 Keiya Ozawa Libération de facteurs angiogéniques à médiation virale et adéno associée
DE60129229T2 (de) * 2000-08-17 2008-05-08 Ozawa, Keiya Adeno-assoziierte virus-vermittelte übertragung von angiogenesefaktoren
WO2002019966A2 (fr) * 2000-09-06 2002-03-14 Johns Hopkins University Procedes de traitement de l'arrhythmie cardiaque
WO2002098432A1 (fr) * 2001-06-01 2002-12-12 The Brigham And Women's Hospital, Inc. Procedes de traitement de troubles cardiaques
US8003618B2 (en) 2002-10-02 2011-08-23 The John Hopkins University Focal calcium channel modulation
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
GB2437893A (en) * 2006-07-25 2007-11-07 Celladon Corp Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
WO2009105135A1 (fr) 2008-02-19 2009-08-27 Celladon Corporation Compositions pour un captage amélioré de vecteurs viraux dans le myocarde
EP2714709B1 (fr) 2011-05-26 2018-04-18 University of Washington Compositions pour utilisations dans des procédés basés sur des cellules et des gènes permettant d'améliorer la fonction cardiaque
EP3710043B1 (fr) 2017-11-16 2024-04-17 Universite d'Aix-Marseille Fgf10 pour le traitement de maladies cardiaques
US12460226B2 (en) 2018-04-16 2025-11-04 The Trustees Of The University Of Pennsylvania Compositions and methods for treating duchenne muscular dystrophy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012050A1 (fr) * 1995-09-27 1997-04-03 The Rockefeller University Procede de transfert de genes vers le coeur a l'aide de vecteurs de virus adeno-associes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792483A (en) * 1993-04-05 1998-08-11 Vickers, Inc. Injection molding machine with an electric drive

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012050A1 (fr) * 1995-09-27 1997-04-03 The Rockefeller University Procede de transfert de genes vers le coeur a l'aide de vecteurs de virus adeno-associes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KESSLER P D ET AL: "SODIUM BUTYRATE GREATLY ENHANCES THE EFFICIENCY OF VIRAL TRANSDUCTION IN ADULT VENTRICULAR CARDIOMYOCYTES BY ADENO-ASSOCIATED VIRAL VECTORS", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 92, no. 8, 15 October 1995 (1995-10-15), pages 1408, XP000673503, ISSN: 0009-7322 *
MAEDA ET AL: "Efficient Gene Transfer into Cardiac Myocytes Using Adeno-Associated Virus (AAV) Vectors", J MOL CELL CARDIOL, vol. 30, July 1998 (1998-07-01), pages 1341 - 1348 *
See also references of WO0038518A1 *

Also Published As

Publication number Publication date
AU2394200A (en) 2000-07-31
JP2002533359A (ja) 2002-10-08
WO2000038518A1 (fr) 2000-07-06
AU763049B2 (en) 2003-07-10
EP1139751A1 (fr) 2001-10-10
WO2000038518A9 (fr) 2002-04-11
CA2356551A1 (fr) 2000-07-06

Similar Documents

Publication Publication Date Title
FR2727867B1 (fr) Transfert de genes dans les motoneurones medullaires au moyen de vecteurs adenoviraux
EP1139751A4 (fr) TRANSFERT EFFICACE ET STABLE $i(IN VIVO) DE GENES DANS DES CARDIOMYOCYTES A L'AIDE DE VECTEURS VIRAUX ADENO-ASSOCIES DE RECOMBINAISON
IL132673A0 (en) Gene transfer with adenoviruses having modified fiber proteins
FR2725726B1 (fr) Vecteurs viraux et utilisation en therapie genique
WO2000020557A3 (fr) Vecteurs de geminivirus destines a l'expression genique dans les vegetaux
EP0981649A4 (fr) Peptides favorisant le transport d'un agent actif dans les tissus, compositions les renfermant et leurs procedes d'utilisation
NO975953L (no) Rekombinante adenoviruser, deres anvendelse for fremstilling av AAV'er, komplementær cellelinje samt farmasöytiske preparater inneholdende adenovirusene
IL131209A0 (en) Recombinant haloaliphatic dehalogenases
ZA989012B (en) Chlamydia protein gene sequence and uses thereof
AU5464000A (en) Recombinant adenoviral vectors for cell specific infection and genome integration and expressing chimeric fiber proteins
FR2818481B1 (fr) Teletraitement et distribution d'images dans des kiosques
FR2755699B1 (fr) Nouvelles constructions et vecteurs pour l'expression ciblee et inductible des genes
EP1186615A4 (fr) Proteine et adn de cette proteine
IL117466A0 (en) Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy
IT9020072A0 (it) Cellule umane per l'elevata espressione di geni inseriti in dna ricombinanti episomiali,loro preparazione e loro impiego
EP1064947A4 (fr) Vaccination in ovo contre le virus de la maladie de marek, type 1
LU90177B1 (fr) Solution cutanée pour dépôt direct à usage anti-parasitaire chez les bovins et ovins
FR2759708B1 (fr) Moyens pour identifier, isoler et caracteriser des sequences nucleotidiques impliquees dans l'apomixie
EP1162887A4 (fr) Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation
EP1124840A4 (fr) Genes et proteines specifiques aux ovaires
FR2766145B1 (fr) Attache de levage et groupe moto-propulseur equipe d'une telle attache
IL147071A0 (en) Nucleic and proteinic acids corresponding to human gene abc1
EP1181316A4 (fr) RECEPTEURS SNORF 36a ET SNORF 36b CODANT POUR L'ADN
FR2795732B1 (fr) Utilisation du gene krit1 dans le domaine de l'angiogenese
FR2781503B1 (fr) Nouveaux vecteurs derives de baculovirus et utilisation pour le transfert d'acides nucleiques dans les cellules nerveuses

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010726

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030204

17Q First examination report despatched

Effective date: 20031103

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20090312